Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1060)	11/5/1998 10:18:00 PM
From: NASDBULL	Read Replies (2) \| Respond to of 3576

If you think the bio-tech sector was hit because of ENMD, you're an idiot! I'm convinced you are short GERN. This isn't about bio-tech fundamentals, this is hype.....people make a lot of money on hype....and the opposite is true also..... The market is full of hype and people don't "damn the sector", just because of one stock.... This finding is mindboggling and HUGE, I don't think you understand the ramifications of this finding. GERN will make a significant amount of money in licensing alone.....the thought of the long-term prospects for GERN are immense. You need to cover your position and stop all your, "I like GERN. I like the science. The market cap is $110 million. Why would you buy this company for a project that is, if rational, ten years from clinic when you can buy companies that are selling at or near book with near-term prospects, advanced projects, and market caps that are significantly lower?" NASDBULL